This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Healthbiome. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Dong-Hee Choi in Neuroprotection
Introduction
Dong-Hee Choi is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of neuroprotection through his innovative research and patents. His work focuses on developing solutions for degenerative brain diseases, which are increasingly prevalent in today's society.
Latest Patents
Dong-Hee Choi holds a patent for a specific strain that has prophylactic or therapeutic effects on degenerative brain diseases. This strain, known as SR79, has shown potential in inhibiting neuroinflammation and improving movement regulation, cognitive, and memory functions in animal models suffering from conditions such as Parkinson's disease and Alzheimer's disease. The applications of this strain extend to foods, medicines, and feeds, making it a valuable asset in the relevant industries.
Career Highlights
Throughout his career, Dong-Hee Choi has been dedicated to advancing the understanding and treatment of neurodegenerative disorders. His innovative approach has led to the development of effective solutions that can potentially improve the quality of life for individuals affected by these diseases.
Collaborations
Dong-Hee Choi has collaborated with notable colleagues, including Byoung-Chan Kim and Chul-Ho Lee. These partnerships have fostered a collaborative environment that enhances research and development in the field of neuroprotection.
Conclusion
In summary, Dong-Hee Choi's contributions to the field of neuroprotection through his innovative patent and collaborative efforts highlight his commitment to addressing the challenges posed by degenerative brain diseases. His work is paving the way for future advancements in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile